# Study of Gelonin Purging of Autologous Stem Cells for Transplantation

> **NCT00043810** · PHASE1,PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome

## Interventions

- **PROCEDURE:** Gelonin
- **DRUG:** Busulfan
- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT00043810
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2018-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043810, "Study of Gelonin Purging of Autologous Stem Cells for Transplantation". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00043810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*